Research & Development Solutions — Segment profit
IQVIA Research & Development Solutions — Segment profit increased by 1.3% to $472.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $460.00M to $472.00M. Over 4 years (FY 2021 to FY 2025), Research & Development Solutions — Segment profit shows an upward trend with a 6.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase signals improved operational performance, higher margins, or successful cost management, while a decrease indicates margin compression or operational challenges.
Detailed definition
Represents the operating income generated by the research and development segment after accounting for direct costs and...
Peer comparison
Comparable to segment operating income or segment EBITDA reported by diversified healthcare and service companies.
iqv_segment_research_development_solutions_segment_profitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $343.00M | $364.00M | $407.00M | $401.00M | $398.00M | $445.00M | $451.00M | $428.00M | $468.00M | $495.00M | $524.00M | $479.00M | $493.00M | $498.00M | $478.00M | $460.00M | $451.00M | $496.00M | $466.00M | $472.00M |
| QoQ Change | — | +6.1% | +11.8% | -1.5% | -0.7% | +11.8% | +1.3% | -5.1% | +9.3% | +5.8% | +5.9% | -8.6% | +2.9% | +1.0% | -4.0% | -3.8% | -2.0% | +10.0% | -6.0% | +1.3% |
| YoY Change | — | — | — | — | +16.0% | +22.3% | +10.8% | +6.7% | +17.6% | +11.2% | +16.2% | +11.9% | +5.3% | +0.6% | -8.8% | -4.0% | -8.5% | -0.4% | -2.5% | +2.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IQVIA's research & development solutions — segment profit?
- IQVIA (IQV) reported research & development solutions — segment profit of $472.00M in Q1 2026.
- How has IQVIA's research & development solutions — segment profit changed year-over-year?
- IQVIA's research & development solutions — segment profit increased by 2.6% year-over-year, from $460.00M to $472.00M.
- What is the long-term trend for IQVIA's research & development solutions — segment profit?
- Over 4 years (2021 to 2025), IQVIA's research & development solutions — segment profit has grown at a 6.1% compound annual growth rate (CAGR), from $1.48B to $1.87B.
- What does research & development solutions — segment profit mean?
- The operating profit generated specifically by the clinical research and development services division.